[1] 刘明波,何新叶,杨晓红,等.《中国心血管健康与疾病报告2023》要点解读[J].中国心血管杂志,2024,29(4):305-324.
[2] EZEKOWITZ J A,KAUL P,BAKAL J A,et al.Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction[J].J Am Coll Cardiol,2009,53(1):13-20.
[3] DE WAHA S,PATEL M R,THIELE H,et al.Relationship between infarct artery,myocardial injury,and outcomes after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction[J].J Am Heart Assoc,2024,13(18):e034748.
[4] AKHTAR K H,KHAN M S,BARON S J,et al.The spectrum of post-myocardial infarction care:From acute ischemia to heart failure[J].Prog Cardiovasc Dis,2024,82:15-25.
[5] KRETZ M,WEBSTER D E,FLOCKHART R J,et al.Suppression of progenitor differentiation requires the long noncoding RNA ANCR[J].Genes Dev,2012,26(4):338-343.
[6] TIAN Y T,SUN H X,ZHOU X H,et al.Long non-coding RNA DANCR alleviates acute myocardial infarction damage via regulating microRNA-509-5p/KLF transcription factor 13 pathway[J].Kaohsiung J Med Sci,2023,39(7):652-664.
[7] LI J,XIE J,WANG Y Z,et al.Overexpression of lncRNA Dancr inhibits apoptosis and enhances autophagy to protect cardiomyocytes from endoplasmic reticulum stress injury via sponging microRNA-6324[J].Mol Med Rep,2021,23(2):116.
[8] HUANG Q,HUANG Q.Inhibition of lncRNA DANCR prevents heart failure by ameliorating cardiac hypertrophy and fibrosis via regulation of the miR-758-3p/PRG4/smad axis[J].J Cardiovasc Transl Res,2023,16(6):1357-1372.
[9] WANG D,WANG X,YANG T,et al.Long non-coding RNA dancr affects myocardial fibrosis in atrial fibrillation mice via the microRNA-146b-5p/Smad5 axis[J].Acta Cardiol Sin,2023,39(6):841-853.
[10] ZHANG R,HAO Y,ZHANG J.The lncRNA DANCR promotes development of atherosclerosis by regulating the miR-214-5p/COX20 signaling pathway[J].Cell Mol Biol Lett,2022,27(1):15.
[11] AN F,YIN Y,JU W.Long noncoding RNA DANCR expression and its predictive value in patients with atherosclerosis[J].Bioengineered,2022,13(3):6919-6928.
[12] BYRNE R A,ROSSELLO X,COUGHLAN J J,et al.2023 ESC Guidelines for the management of acute coronary syndromes[J].Eur Heart J,2023,44(38):3720-3826.
[13] FUSCO A,HANSEN M L,RUWALD M H,et al.Temporal trends in atrial fibrillation ablation in the elderly:incidence of MACE and recurrence rates[J].JACC Clin Electrophysiol,2025,11(1):83-94.
[14] 中国医师协会心血管内科医师分会,中国心血管健康联盟,心肌梗死后心力衰竭防治专家共识工作组.2020心肌梗死后心力衰竭防治专家共识[J].中国循环杂志,2020,35(12):1166-1180.
[15] FRANGOGIANNIS N G.Pathophysiology of myocardial infarction[J].Compr Physiol,2015,5(4):1841-1875.
[16] SELEJAN S R,HOHL M,BÖHM M.Post-infarction cardiac remodeling-differential biomarkers for left atrial and left ventricular remodeling[J].J Mol Med,2021,99(7):957-958.
[17] IBANEZ B,JAMES S,AGEWALL S,et al.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC)[J].Eur Heart J,2018,39(2):119-177.
[18] JERNBERG T,HASVOLD P,HENRIKSSON M,et al.Cardiovascular risk in post-myocardial infarction patients:nationwide real world data demonstrate the importance of a long-term perspective[J].Eur Heart J,2015,36(19):1163-1170.
[19] Fourth universal definition of myocardial infarction(2018)[J].Rev Esp Cardiol(Engl Ed),2019,72(1):72.
[20] JANUZZI J L,VAN KIMMENADE R,LAINCHBURY J,et al.NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure:an international pooled analysis of 1256 patients:the International Collaborative of NT-proBNP Study[J].Eur Heart J,2006,27(3):330-337.
[21] PARIKH R H,SELIGER S L,CHRISTENSON R,et al.Soluble ST2 for prediction of heart failure and cardiovascular death in an elderly,community-dwelling population[J].J Am Heart Assoc,2016,5(8):e003188.
[22] QAMAR A,GIUGLIANO R P,BOHULA E A,et al.Biomarkers and clinical cardiovascular outcomes with ezetimibe in the IMPROVE-IT trial[J].J Am Coll Cardiol,2019,74(8):1057-1068.
[23] YAGHOOBI A,REZAEE M,BEHNOUSH A H,et al.Role of long noncoding RNAs in pathological cardiac remodeling after myocardial infarction:an emerging insight into molecular mechanisms and therapeutic potential[J].Biomed Pharmacother,2024,172:116248.
[24] ZHANG F,SU S,HOU Y,et al.Effects(MACE and bleeding events) of ticagrelor combined with omeprazole on patients with acute myocardial infarction undergoing primary PCI[J].Hellenic J Cardiol,2020,61(5):306-310.
[25] FADAEI S,ZAREPOUR F,PARVARESH M,et al.Epigenetic regulation in myocardial infarction:non-coding RNAs and exosomal non-coding RNAs[J].Front Cardiovasc Med,2022,9:1014961.
[26] BO X,LI Q,CHEN S,et al.Evidence and perspectives on miRNA,circRNA,and lncRNA in myocardial ischemia-reperfusion injury:a bibliometric study[J].J Cardiothorac Surg,2025,20(1):66. |